Recruiting
A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship
About this study
The goal of this trial is to learn if a resilience intervention can lead to improvements in lymphoma survivors' quality of life.
- Condition
- Lymphoma
- Tested
- Health Education Program, SMART3RP-Lymphoma
- Sponsor
- Massachusetts General Hospital
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 4
- Minimum age: 18 years
- Study condition: Lymphoma
- English or Spanish speaking adults (18+ at time of enrollment)
- Within 1-5 years of completing active treatment for lymphoma (includes surgery, chemotherapy, immunotherapy, radiation therapy, or other); individuals may be on maintenance treatment.
Exclusion 1
- Active psychiatric, medical concern or cognitive comorbidity as determined by the site PI or treating clinician
Where
2 sites, 2 recruiting
Mass General Hospital
Boston, Massachusetts, United States
Huntsman Cancer Institute
Salt Lake City, Utah, United States
Potential match only. Final eligibility is determined by the study team.